Edmund K. Waller
Gründer bei Cambium Medical Technologies LLC
Aktive Positionen von Edmund K. Waller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cambium Medical Technologies LLC
 Cambium Medical Technologies LLC BiotechnologyHealth Technology Cambium Medical Technologies LLC develops and markets regenerative therapies derived from novel processed human platelets. The company was founded by Terence A. Walts, Jacques Galipeau, John D. Roback, Edmund K. Waller and Ian Copland in 2013 and is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | 01.08.2013 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 | - | |
| Gründer | 01.08.2013 | - |
Karriereverlauf von Edmund K. Waller
Ehemalige bekannte Positionen von Edmund K. Waller
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CAMBIUM BIO LIMITED | Direktor/Vorstandsmitglied | 05.04.2024 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 05.04.2024 | - | |
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
Ausbildung von Edmund K. Waller
| The Rockefeller University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Australien | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
Cambium Medical Technologies LLC
Cambium Medical Technologies LLC BiotechnologyHealth Technology Cambium Medical Technologies LLC develops and markets regenerative therapies derived from novel processed human platelets. The company was founded by Terence A. Walts, Jacques Galipeau, John D. Roback, Edmund K. Waller and Ian Copland in 2013 and is headquartered in Atlanta, GA. | Health Technology |
Regeneus Ltd.
 Regeneus Ltd. Pharmaceuticals: MajorHealth Technology Regeneus Ltd. is regenerative medicine company, which develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Paddington, Australia. | Health Technology |
- Börse
- Insiders
- Edmund K. Waller
- Erfahrung
